Moderna Sees 41 Percent Q2 Revenue Drop as COVID Vaccine Sales Decline
Moderna posted USD 142 million in revenue for the second quarter 2025, down 41 percent from USD 241 million in the same period last year.
COVID Vaccine | 04/08/2025 | By Dineshwori | 160
AD Ports Group, Hayat Biotech partner to upgrade logistics solutions
The facilities will produce several vital biopharmaceutical products, including the Hayat-Vax vaccine, the first indigenously produced COVID-19 vaccine in the UAE
Covid Vaccine | 15/07/2022 | By Sudeep Soparkar | 748
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy